Coforge gets listing approval for 93.8 million shares
Coforge Limited secured in-principle approval from stock exchanges on May 22, 2026, to list 93,796,508 equity shares of ₹2 face value each. These shares were allotted on a preferential basis to Encora US Holdco, Inc. and Encora Holdings Ltd. on April 23, 2026, pursuant to a Share Subscription and Share Purchase Agreement. The company has filed the necessary corporate action with depositories to credit the shares to the allottees' demat accounts.

*this image is generated using AI for illustrative purposes only.
Coforge Limited has received in-principle approval from stock exchanges to list 93,796,508 equity shares. The approval was granted on May 22, 2026, following the company's preferential allotment of these shares.
The shares, with a face value of ₹2 each, were allotted on a preferential basis. This allotment was part of a Share Subscription and Share Purchase Agreement executed with Encora US Holdco, Inc. and Encora Holdings Ltd. The company had previously informed the exchanges about the in-principle approval for the preferential issue on April 10, 2026, and the subsequent allotment on April 23, 2026.
Pursuant to the latest approval, Coforge has filed the corporate action with the depositories. This step ensures the credit of the equity shares to the demat accounts of the respective allottees.
| Detail | Information |
|---|---|
| Total Equity Shares | 93,796,508 |
| Face Value | ₹2 |
| Approval Date | May 22, 2026 |
| Allotment Date | April 23, 2026 |
The intimation regarding this development has been uploaded on the company's official website.
Historical Stock Returns for Coforge
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.79% | +9.04% | +13.13% | -22.23% | -15.40% | +112.44% |
How will the listing of these 93.8 million shares impact Coforge's existing shareholding structure and liquidity?
What strategic benefits does Coforge expect from its partnership with Encora US Holdco and Encora Holdings post-allotment?
Could this preferential allotment dilute earnings per share (EPS) for current shareholders in the near term?


































